For the first time, the International Experimental Medicine and Biology Conference is coming to the UK, with a focus on cancer immunotherapy and biotherapeutics.

Recently returned from the MedCity delegation to Japan, Farzin Farzaneh – Professor of Molecular Medicine and Director of Cell and Gene Therapy at King’s College London – is co-hosting the 7th annual Conference from 21-23 November.

Professor Farzaneh spoke on advanced cell therapy and immuno-oncology at the Link-J symposium at Tokyo and at Kobe.

The Cancer Immunotherapy and Biotherapeutics conference on 21-23 November provides an excellent opportunity for researchers, industry, students and clinicians to come together to explore significant breakthroughs in our understanding of the biology and immunotherapy of cancer.

For those working in or interested in Cancer Immunotherapy & Biotherapeutics, the Society for Experimental Biology and Medicine and King’s College London have curated a packed program of international talks, including:

  • Amato Giaccia, University of Oxford – The past, present and future of combining radiotherapy and immune therapy
  • Beth Helmink, MD Anderson –  The role of the gut microbiome in the response to immune checkpoint blockade in melanoma patients
  • Christian Buchholz, Paul-Ehrlich-Institut, Germany – In Vitro Generation of CAR T cells
  • Karin Gaensler, University of California, San Francisco – Immune gene therapy of cancer – tumour cells as cancer vaccines
  • Martin Pule, University College London/Autolus – CAR T-cell therapy for ALL
  • Ravid Straussman, Weizmann Institute of Science, Israel – The tumor microbiome and its effects on resistance to anti-cancer therapies

Major areas of focus include tumour immunology and immune therapy of cancer, cell and gene therapy-based interventions and the impact of tumour microenvironment and the microbiome on the therapeutic response to novel and classical cancer therapies.

This Conference will invite discussion around the latest research, development of new therapeutics and clinical treatment of cancer. An exciting programme of lectures will be combined with ample opportunities for discussions, networking, demonstrations and social events.

Tickets are available here and if you are an Advanced Therapies Network member, you get a 50% discount: